Examining global COVID-19 vaccinations and “antipoverty vaccines” using recombinant DNA technology: Science vs. antiscience

Originally aired: Tuesday, 27 September 2022

Now available on demand! Please register to view.

If you’ve already registered, please click here to login to the webinar.

Sign Up:

Email *

* Required

Confirm Email *

* Required

First Name *

* Required

Last Name *

* Required

Company *

* Required

State/Province *

* Required

Job Title *

* Required

In which type of organization are you currently working or studying? (Please pick the best option) *

* Required

If you picked Other above, please specify:

* Required

Have you ever used Sino Biological's products (e.g., recombinant proteins and antibodies) or CRO services? *

* Required

Do you have a need for customized production of proteins, antibodies, or bioanalysis services? *

* Required

What other webinar topics would you be interested in learning about in the future? *

* Required

Do you live in California? *

* Required

Check this box to agree to receive occasional email or other contact from Science/AAAS about their programs, products, services and other offerings. Science/AAAS agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time. * Required

Country/Region:*

* Required

Check this box to agree to receive occasional email or other contact from the sponsor of this webinar about their programs, products, services and other offerings. The sponsor agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time by contacting the sponsor.

Check this box to agree to receive occasional email or other contact from Science/AAAS about their programs, products, services and other offerings. Science/AAAS agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time.

Except for California residents:
By clicking "Register" you agree to receive occasional email or other contact from the sponsor of this webinar about their programs, products, services and other offerings. The sponsor agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time by contacting the sponsor. You also agree to receive occasional email or other contact from the Science/AAAS about their programs, products, services and other offerings. Science/AAAS agrees not to rent, sell, exchange, or give your information to any third party without permission. You may opt out of these emails at any time.

* Required

Science/AAAS Privacy Policy

* Required

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

Overview

How does one put a price tag on a pandemic? Now entering its third year, COVID-19 and the economic toll it has taken is still being figured out by researchers and health policy experts who hope to provide evidence of vaccine rollouts and get ahead of new variants of the virus. The cost of COVID-19 in lives lost, medical expenses, and economic impact has been severe. It has killed an estimated 15 million people worldwide, and 4 million Americans are living with the lasting symptoms known as long COVID. One article even dubbed it “the $16 Trillion Virus.”

Vaccination has been known as the most successful health strategy for the prevention of infectious diseases and their subsequent disability conditions. Yet equal access to vaccines and aggressive antiscience sentiment remain as hurdles. The Texas Children’s Hospital Center for Vaccine Development developed a low-cost, patent-free recombinant protein COVID-19 “people’s vaccine” (CORBEVAX) that has been administered to more than 70 million adolescents and children in India and was just approved in Botswana. In the United States, substantial progress has been made in vaccinating the population against COVID-19, with the important exception of an estimated 200,000 unvaccinated Americans who lost their lives because they refused COVID-19 vaccinations. Antivaccine defiance has evolved over the last 20 years, starting with disinformation about vaccines causing autism but now culminating around a framework of health or medical freedom that has started to globalize to Canada, Western Europe, and increasingly to low- and middle-income countries. This sentiment targets both biomedical science and scientists with dangerous consequences for the nation but also for worldwide vaccinations and other health and science interventions.

During this webinar, viewers will:

Learn about the impact of neglected tropical diseases and COVID-19 among unvaccinated populations in the United States and globally
Gain insight into the origins of rising antivaccine sentiment, its recent shifts, and approaches to countering antivaccine activities
Discover how recombinant DNA technology is used and plays a vital role in vaccine development.

Presenters

Speaker: Peter Hotez, M.D., Ph.D.

Baylor College of Medicine
Houston, TX
View Bio

Speaker: Shebna Massey, Ph.D.

Sino Biological US Inc.
Houston, TX
View Bio

Moderator: Jackie Oberst, Ph.D

Science/AAAS
Washington, DC
View Moderator Biography